Cambridge Trust’s Concentrix CNXC Stock Holding History

Cambridge Trust’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7	Closed	-$1K	–	957
2021 Q4	$1K	Buy	+7	New	+$1.25K	﹤0.01%	984

Other funds holding CNXC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Cambridge Trust's CNXC Position: Q1 2022 in Review

Cambridge Trust sold out of Concentrix (CNXC) in Q1 2022, closing a stake of 7 shares — an estimated $1K sold.

Cambridge Trust first reported a position in CNXC in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 354 funds tracked by Wall St. Rank hold CNXC as of Q1 2022.

Cambridge Trust reported no remaining Concentrix position as of Q1 2022 after selling out during the quarter.
Cambridge Trust sold 7 Concentrix shares in Q1 2022, an estimated $1K.
Cambridge Trust first reported a position in Concentrix in Q4 2021 and held it in 1 quarter.
Cambridge Trust's Concentrix position peaked at $1K in Q4 2021.
354 funds tracked by Wall St. Rank held Concentrix as of Q1 2022.

Based on Cambridge Trust's 13F filing for Q1 2022, filed 12 May 2022.